(Press-News.org) Scientists at Paderborn University have used a new method to determine the characteristics of optical, i.e. light-based, quantum states. For the first time, they are using certain photon detectors - devices that can detect individual light particles - for so-called homodyne detection. The ability to characterise optical quantum states makes the method an essential tool for quantum information processing. Precise knowledge of the characteristics is important for use in quantum computers, for example. The results have now been published in the specialist journal "Optica Quantum".
"Homodyne detection is a method frequently used in quantum optics to investigate the wave-like nature of optical quantum states," explains Timon Schapeler from the Paderborn "Mesoscopic Quantum Optics" working group at the Department of Physics. Together with Dr Maximilian Protte, he has used the method to investigate the so-called continuous variables of optical quantum states. This involves the variable properties of light waves. These can be, for example, the amplitude or phase, i.e. the oscillation behaviour of waves, which are important for the targeted manipulation of light, among other things.
For the first time, the physicists have used superconducting nanowire single photon detectors for the measurements - currently the fastest devices for photon counting. With their special experimental setup, the two scientists have shown that a homodyne detector with superconducting single photon detectors has a linear response to the input photon flux. Translated, this means that the measured signal is proportional to the input signal.
"In principle, the integration of superconducting single-photon detectors brings many advantages in the area of continuous variables, not least the intrinsic phase stability. These systems also have almost 100 per cent on-chip detection efficiency. This means that no particles are lost during detection. Our results could enable the development of highly efficient homodyne detectors with single-photon sensitive detectors," says Schapeler.
Working with continuous variables of light opens up new and exciting possibilities in quantum information processing beyond qubits, the usual computing units of quantum computers.
Read the article:https://doi.org/10.1364/OPTICAQ.502201.
END
Measuring the properties of light: Scientists realise new method for determining quantum states
2024-02-25
ELSE PRESS RELEASES FROM THIS DATE:
For faster access to gene and cell therapies in Europe
2024-02-25
Gene and cell therapies are among the most important innovations in the healthcare sector. And they reflect advances in science and technology. They have the potential to radically reshape the treatment of cancer, autoimmune diseases, neurodegenerative disorders, and many rare genetic conditions. But the path to approval and clinical use of these products is long and often fraught with difficulty.
That was the reason the European University Hospital Alliance (EUHA) founded the European Center for Cell and Gene Cancer Therapies (EUCCAT) four years ago. The center’s aim is to facilitate the clinical use of ATMPs developed at higher education institutions and further ...
Scientists deliver portable total chemical analysis without pumps and tubes
2024-02-24
Tokyo, Japan – Researchers from Tokyo Metropolitan University have engineered a new micro total analysis system that quantifies a target chemical in a microfluidic chip without pumps, tubes, and expensive detectors. The compound reacts with other chemicals to produce a gas, pushing ink in a connected chamber along a channel. Built-in light detectors help measure the flow speed, allowing measurement of the original chemical. The portability of the new device enables bedside, quantitative clinical analysis.
Microfluidics is a revolutionary technology delivering precision chemistry with vastly less chemicals. ...
A very long, winding road: Developing novel therapeutics for metastatic tumors
2024-02-23
“Given that the MET inhibitor capmatinib caused a remarkable response in Dr. Blagosklonny, a pertinent question remains as to why he was not treated with ‘preemptive drug combinations’ [...]”
BUFFALO, NY- February 23, 2024 – A new editorial paper was published in Oncoscience (Volume 11) on February 9, 2024, entitled, “A very long and winding road: developing novel therapeutics for metastatic tumors.”
In this editorial, researcher Paul Dent from the Department of Biochemistry and Molecular Biology at Virginia Commonwealth University writes that tumors that ...
Unlocking health: How In Our DNA SC is pioneering genetic screening for South Carolinians
2024-02-23
Physicians and scientists have known for many years that our genetics not only shape our physical features like our smiles but also our risk for developing certain diseases.
The problem? Most people don’t know if they have inherited these genetic risk factors for disease.
In Our DNA SC, a statewide genomic screening program launched by the Medical University of South Carolina (MUSC), aims to change that.
The program, the first and only program of its kind in the Southeast, is led by Caitlin G. Allen, Ph.D., a ...
Down Under Demo: ONR touts additive manufacturing tech at Australian event
2024-02-23
ARLINGTON, Va.—The Office of Naval Research (ONR) — and its international arm, ONR Global — participated in the recent Autonomous Warrior 2023 (AW23) exercise, located at HMAS Creswell in Jervis Bay, Australia.
AW23 brought together Australian military allies, as well as industry and international partners, to demonstrate various technologies designed to help the Royal Australian Navy strengthen its capabilities in the area of undersea warfare — including uncrewed (also called unmanned) and autonomous systems, artificial intelligence and machine learning, and logistics, ...
Study shows benralizumab is effective as a treatment for eosinophilic granulomatosis with polyangiitis, a rare form of vasculitis
2024-02-23
Researchers have shown that the drug benralizumab is as effective and safe as mepolizumab for inducing remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) according to a study published today in The New England Journal of Medicine. The results of the non-inferiority study were presented at the American Academy of Allergy, Asthma & Immunology annual meeting in Washington, D.C., by Michael Wechsler, M.D., pulmonologist, director of The Cohen Family Asthma Institute at National Jewish Health and lead author of the paper.
EGPA is a rare form of vasculitis, characterized by inflammation in the small blood vessels. This inflammation ...
Researchers identify new choice of therapy for rare autoimmune disease EGPA
2024-02-23
An international team, including researchers from McMaster University and St. Joseph’s Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior to mepolizumab in the treatment of EGPA.
In a clinical trial involving 140 patients with the rare disease, researchers directly compared two biologic drugs, mepolizumab and benralizumab. Patients received monthly subcutaneous injections of either 300 mg of mepolizumab or 30 mg of benralizumab for one year. The findings of the trial were published on Feb. 23, 2024, in the New ...
Powering nitrogenases
2024-02-23
Nitrogenases are considered promising candidates for the sustainable enzymatic production of ammonia and carbon compounds. Unfortunately, one bottleneck in this complex process, the supply of electrons to the enzymes, has remained a mystery until now. Now a team at the Max Planck Institute for Terrestrial Microbiology in Marburg has discovered two essential electron carriers which play a key role in determining the performance of iron (Fe) nitrogenase, thus opening up new possibilities for elucidating and maximizing nitrogenase's potential.
Nitrogenases are catalysts for several industrially relevant ...
NJIT marketing experts measure brain waves and skin current to predict emotions
2024-02-23
Machines still can’t think, but now they can validate your feelings, based on new research from New Jersey Institute of Technology Assistant Professor Jorge Fresneda.
Fresneda started his career as a chemist and then became an expert in neuroanalytics. He studies how measurements of brain activity and skin conductance can predict a person’s emotions with high accuracy, and how such information can be used in fields such as entertainment, management, marketing and well-being.
“Neuromarketing is a subfield within marketing ...
Babies use immune system differently, but efficiently
2024-02-23
ITHACA, N.Y. – Scientists have long believed that a newborn’s immune system was an immature version of an adult’s, but new research from Cornell University shows that newborns’ T cells – white blood cells that protect from disease – outperform those of adults at fighting off numerous infections.
These results help clarify why adults and infants respond differently to infections and pave the way for controlling T cells’ behavior for therapeutic applications.
This discovery was described in a paper published in Science Immunology on Feb. 23, co-led by Brian Rudd, associate professor of microbiology ...